Ceapro Inc. to Present at the H.C. Wainwright Global Life Sciences Conference
Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF), a Canadian biotechnology company specializing in active ingredients for healthcare and cosmetics, announced its participation in the H.C.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF), a Canadian biotechnology company specializing in active ingredients for healthcare and cosmetics, announced its participation in the H.C. Wainwright Global Life Sciences Conference on March 9-10, 2021. CEO Gilles Gagnon will present and engage in one-on-one meetings with investors. A video webcast of the presentation will be available on-demand starting March 9, 2021, at 7:00 AM ET, accessible for 90 days on the company's website.
Details
News Market Reaction – CRPOF
The recorded move for CRPOF in the trading session of this news was +2.04%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
EDMONTON, Alberta, March 03, 2021 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced today that Gilles Gagnon, President and Chief Executive Officer of Ceapro will present at the virtual H.C. Wainwright Global Life Sciences Conference taking place March 9-10, 2021.
In addition to the presentation, management will also be available to participate in virtual one-on-one meetings with qualified members of the investor community who are registered to attend the conference. For more information about the conference, please visit the conference website here.
The video webcast presentation will be available for viewing on-demand beginning Tuesday, March 9, 2021, at 7:00 AM ET for those registered for the event and will be accessible on the IR Calendar page of the Investors section of the Company's website (www.ceapro.com) and will be archived for 90 days following the event.
About Ceapro Inc.
Ceapro Inc. is a Canadian biotechnology company involved in the development of proprietary extraction technology and the application of this technology to the production of extracts and “active ingredients” from oats and other renewable plant resources. Ceapro adds further value to its extracts by supporting their use in cosmeceutical, nutraceutical, and therapeutics products for humans and animals. The Company has a broad range of expertise in natural product chemistry, microbiology, biochemistry, immunology and process engineering. These skills merge in the fields of active ingredients, biopharmaceuticals and drug-delivery solutions. For more information on Ceapro, please visit the Company’s website at www.ceapro.com.
For more information contact:
Jenene Thomas
JTC Team, LLC
Investor Relations and Corporate Communications Advisor
T (US): +1 (833) 475-8247
E: czo@jtcir.com
Issuer:
Gilles R. Gagnon, M.Sc., MBA
President & CEO
T: 780-421-4555
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.